Coxsackievirus B4 in southern Taiwan: molecular epidemiology.

J Clin Virol

Department of Medical Laboratory Science and Biotechnology, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.

Published: May 2009

Background: Enterovirus outbreaks caused by Coxsackievirus B4 (CB4) in Taiwan in 2004 and 2008.

Objective: To retrospectively analyze the molecular epidemiology and pathogenicity of CB4 in Taiwan.

Study Design: This study analyzed twenty-three CB4 strains isolated in Taiwan during 1993-2004. Sequence variations data were obtained using 420 bp of VP4/VP2 region and 331 bp of 3' VP1 region. Phylogenetic dendrograms were constructed with other CB4 sequences in Genebank. The clinical manifestations of CB4 infection were examined by retrospectively reviewing medical records of infected patients.

Results: Three CB4 genotypes were identified: genotypes II, IVb and VIII. Genotype VIII, a new and geographically distinct cluster, has been isolated in South Korea, China and Taiwan. This genotype was isolated in twelve of twenty-three CB4 patients treated in Taiwan during 1997-2004. Eight of twenty-three strains belonging to genotype II, now the major genotype worldwide, were first identified in Taiwan in 2000. Three isolates (identified 1993-1994) analyzed in this study belonged to genotype IVb. In this retrospective follow-up study of sixteen patients with CB4 infection, the median patient age at the time of infection diagnosis was 4-year-old (range, 18 days to 10-year-old), and male-female ratio was 1:1. None of the sixteen patients suffered IDDM or myocarditis after their B4 infection episodes; four had Attention Deficit Hyperactivity Disorder (ADHD) and/or tic disorders (TDs) at follow-up.

Conclusions: Genotypes II and VIII of CB4 have co-circulated in Taiwan since 2000. Controlled studies are needed to evaluate a possible association between ADHD and TDs with CB4 infection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2009.02.012DOI Listing

Publication Analysis

Top Keywords

cb4 infection
12
cb4
10
molecular epidemiology
8
twenty-three cb4
8
taiwan 2000
8
sixteen patients
8
taiwan
7
infection
5
genotype
5
coxsackievirus southern
4

Similar Publications

Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection.

Microbiology (Reading)

October 2024

School of Infection and Immunology, College of Medical, Veterinary and Life Sciences, Sir Graeme Davies Building, University of Glasgow, Glasgow, G12 8TA, UK.

Article Synopsis
  • The gut microbiota significantly impacts human health, with changes linked to various diseases, but the specific cellular mechanisms behind these effects are not fully understood.
  • This study investigated how metabolites derived from the gut microbiome, such as butyrate and l-tryptophan, affect the intestinal barrier and immune responses at a cellular level.
  • Results showed that most metabolites enhance gut barrier function, though butyrate increased cell death while helping maintain barrier integrity, highlighting the complex role of microbiome metabolites in host health and disease.
View Article and Find Full Text PDF

Coronavirus disease 2019 dramatically changed people's behavior because of the need to adhere to infection prevention and to overcome general adversity resulting from the implementation of infection prevention measures. However, coping behavior has not been fully distinguished from risk perception, and a comprehensive picture of demographic, risk-perception, and psychobehavioral factors that influence the major coping-behavior factors remain to be elucidated. In this study, we recruited 2,885 Japanese participants.

View Article and Find Full Text PDF

Essential oils are volatile constituents that give aromatic plants their characteristic odour. The application of these plant actives in food, agriculture, pharmaceutics, and cosmetics has been widely studied. Aromatherapy, a complementary therapy involving the use of essential oils to treat several diseases ranging from microbial infections to metabolic dysfunctions, has been utilised for centuries.

View Article and Find Full Text PDF

With increased use of mass spectrometry imaging (MSI) in support of pharmaceutical research and development, there are opportunities to develop analytical pipelines that incorporate exploratory high-performance analysis with higher capacity and faster targeted MSI. Therefore, to enable faster MSI data acquisition we present analyte-targeted desorption electrospray ionization-mass spectrometry imaging (DESI-MSI) utilizing a triple-quadrupole (TQ) mass analyzer. The evaluated platform configuration provided superior sensitivity compared to a conventional time-of-flight (TOF) mass analyzer and thus holds the potential to generate data applicable to pharmaceutical research and development.

View Article and Find Full Text PDF

Probing multiple proprietary pharmaceutical libraries in parallel via virtual screening allowed rapid expansion of the structure-activity relationship (SAR) around hit compounds with moderate efficacy against , the causative agent of Chagas Disease. A potency-improving scaffold hop, followed by elaboration of the SAR via design guided by the output of the phenotypic virtual screening efforts, identified two promising hit compounds and , which were profiled further in pharmacokinetic studies and in an model of infection. Compound demonstrated clear reduction of parasitemia in the setting, confirming the interest in this series of 2-(pyridin-2-yl)quinazolines as potential anti-trypanosome treatments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!